BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34493600)

  • 21. Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity.
    Dorfman DM; Shahsafaei A; Chan JK
    Am J Surg Pathol; 1997 Aug; 21(8):936-40. PubMed ID: 9255257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
    Chan JK; Tsang WY; Seneviratne S; Pau MY
    Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
    Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
    Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micronodular Thymoma with Lymphoid Stroma Diagnosed with Core Needle Biopsy. A Case Report.
    Chen CW; Chuang SS; Pan ST
    Anal Quant Cytopathol Histpathol; 2015 Jun; 37(3):206-10. PubMed ID: 26173358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
    Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
    Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental model of micronodular thymic neoplasm with lymphoid stroma.
    Niwa R; Hanamatsu Y; Kito Y; Saigo C; Takeuchi T
    Thorac Cancer; 2023 Feb; 14(4):357-362. PubMed ID: 36524622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of CD5 expression in thymic carcinoma: possible mechanism for interaction with CD5+ lymphoid stroma (microenvironment).
    Hosaka N; Ohe C; Miyasaka C; Nakano Y; Sakaida N; Uemura Y; Saito Y; Ikehara S; Tsubura A; Takahashi H
    Histopathology; 2016 Feb; 68(3):450-5. PubMed ID: 26018940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
    Nakagawa K; Matsuno Y; Kunitoh H; Maeshima A; Asamura H; Tsuchiya R
    Chest; 2005 Jul; 128(1):140-4. PubMed ID: 16002927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micronodular thymic epithelial tumors with lymphoid hyperplasia and mimicking lesions.
    Thomas-de-Montpréville V; Chalabreysse L; Hofman V; de-Muret A; Sizaret D; Dubois R; Piton N; Mansuet-Lupo A; Molina TJ
    Histol Histopathol; 2024 May; ():18755. PubMed ID: 38725394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Co-Existence of Micronodular Thymoma and Lymphoma: A Clinicopathological and Immunohistochemical Study of Two Cases.
    Alqaidy D; Moran CA
    Int J Surg Pathol; 2023 Apr; 31(2):152-156. PubMed ID: 35469460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thymoma with epithelial micronodules and lymphoid hyperplasia: six cases of a rare and equivocal subtype].
    Thomas De Montpréville V; Zemoura L; Dulmet E
    Ann Pathol; 2002 Jun; 22(3):177-82. PubMed ID: 12410100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spindle cell and mixed spindle/lymphocytic thymomas: an integrated clinicopathologic and immunohistochemical study of 81 cases.
    Pan CC; Chen WY; Chiang H
    Am J Surg Pathol; 2001 Jan; 25(1):111-20. PubMed ID: 11145245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
    Thomas de Montpréville V; Quilhot P; Chalabreysse L; De Muret A; Hofman V; Lantuéjoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Besse B; Marx A; Molina TJ
    Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micronodular thymoma with lymphoid stroma: As benign as it sounds.
    Chaudhary K; Gala R; Mehta J
    Indian J Pathol Microbiol; 2024 Mar; ():. PubMed ID: 38587095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas.
    Pan CC; Chen PC; Chiang H
    J Pathol; 2004 Mar; 202(3):375-81. PubMed ID: 14991904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Langerhans cells proliferation in ectopic micronodular thymoma with lymphoid stroma: a case report.
    Zhu P; Yan F; Ao Q
    Int J Clin Exp Pathol; 2014; 7(10):7262-7. PubMed ID: 25400824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development.
    Ströbel P; Marino M; Feuchtenberger M; Rouzière AS; Tony HP; Wulbrand U; Förster R; Zettl A; Lee Harris N; Kreipe H; Laeng RH; Müller-Hermelink HK; Marx A
    J Pathol; 2005 Sep; 207(1):72-82. PubMed ID: 15965907
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Bille A; Fryer K; Wallace A; Nonaka D
    J Clin Pathol; 2024 Jan; 77(2):125-127. PubMed ID: 36600564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers.
    Alexiev BA; Drachenberg CB; Burke AP
    Diagn Pathol; 2007 May; 2():13. PubMed ID: 17498299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micronodular Thymic Carcinoma with Lymphoid Stroma: A Case Report.
    Zaitsu K; Nishida H; Kondo Y; Kawamura K; Kusaba T; Oyama Y; Daa T
    Int J Surg Pathol; 2023 Aug; 31(5):785-790. PubMed ID: 36314459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.